News

APhase III trial of Novo Nordisk’s once-daily tablet has met both co-primary endpoints, reducing vaso-occlusive crises (VOC) and increasing haemoglobin (Hb)…

Sickle cell disease (SCD) is characterized by abnormal polymerization of deoxygenated hemoglobin S. This polymerization leads to the distinctive sickling of red…

Sickle cell patients are more likely than other patients to have negative descriptions in their medical charts, such as “noncompliant” and “noncooperative,”…

The Haemoglobinopathy Coordinating Centre (HCC) for the North of England is thrilled to invite you to our rescheduled Sickle Cell Patient Event!After having to…

AbstractBackgroundSickle cell disease (SCD) is one of the most common monogenic disorders in the world. Patients with SCD have chronic hemolytic anemia and…

WEDNESDAY, April 15, 2026 (HealthDay News) —For many patients with sickle cell disease, a trip to the emergency room has an unwanted side-effect: In their search…

Department of Development Studies, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001,…

ABSTRACTObjectiveTo investigate immunophenotypic alterations in regulatory T cells (Tregs) and neutrophil dynamics in adult sickle cell anemia (SCA) patients during…

Patients in sub-Saharan Africa less likely to know details about their disease variant, use over-the-counter medications, and go to the hospital for pain crises(…

Individuals living with sickle cell disease in sub-Saharan Africa face disparities in treatment and health care access when compared with those in other low- and…